SIENTRA, INC. (NASDAQ:SIEN) Files An 8-K Entry into a Material Definitive AgreementItem 1.01. Entry into a Material Definitive Agreement.
| 2.1 | Agreement and Plan of Merger, dated as of June11, 2017, by and among Sientra, Inc., Desert Acquisition Corporation and Miramar Labs, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on June12, 2017) |
| 2.2 | Amendment No.1 to Agreement and Plan of Merger, dated as of June23, 2017 by and among Sientra, Inc., Desert Acquisition Corporation and Miramar Labs, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on June23, 2017). |
About SIENTRA, INC. (NASDAQ:SIEN)
Sientra, Inc. is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. The Company’s breast implants incorporate one or more differentiated technologies, including a cohesive silicone gel and texturing branded TRUE Texture. TRUE Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders and a range of other aesthetic and specialty products. The Company offers a range of HSC+ breast implants, including anatomically shaped textured, round textured and round smooth.
